인슐린 주사기 시장 : 시장 규모, 점유율, 성장 분석 - 주사기 크기별, 질환 유형별, 최종 용도별, 유통 채널별, 지역별 산업 예측(2025-2032년)
Insulin Syringes Market Size, Share, and Growth Analysis, By Syringe Size (3/10 CC Syringe (0.3ml), 1/2 CC Syringe (0.5ml)), By Disease Type (Type 1 Diabetes, Type 2 Diabetes), By End-Use, By Distribution Channel, By Region - Industry Forecast 2025-2032
상품코드:1758592
리서치사:SkyQuest
발행일:2025년 06월
페이지 정보:영문 196 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세계의 인슐린 주사기 시장 규모는 2023년에 17억 달러로 평가되었고, 2024년 17억 7,000만 달러에서 2032년에는 24억 6,000만 달러로 성장할 전망이며, 예측 기간인 2025-2032년 CAGR 4.2%로 성장할 것으로 예측됩니다.
세계 인슐린 주사기 시장은 앉기 쉬운 라이프 스타일, 건강에 해로운 식생활, 도시화, 비만률 증가 등에 부추겨 당뇨병 유병률, 특히 2형 당뇨병이 우려해야 할 기세로 증가하고 있기 때문에 큰 성장을 이루고 있습니다. 국제 당뇨병 연합은 성인의 당뇨병 인구가 2021년 5억 3,700만 명에서 2045년에는 7억 8,300만 명으로 급증할 것으로 예측하고 있으며, 효과적인 인슐린 전달 시스템에 대한 수요가 증가하고 있습니다. 노보 노르디스크와 같은 주요 제약 회사가 기존 인간 인슐린 펜에서 높은 이익률을 가진 GLP-1 수용체 작용제로 축발을 옮기면서 많은 환자, 특히 중저소득국 환자는 적당한 가격의 선택이 줄어들고 있습니다. 그 결과, 특히 고도의 기술을 갖지 않는 헬스케어 환경에서는 기존 인슐린 주사기의 사용이 부활해, 시장 수요를 더욱 밀어 올리고 있습니다.
목차
서문
조사의 목적
조사 범위
정의
조사 방법
정보 조달
2차 및 1차 데이터의 방법
시장 규모 예측
시장의 전제조건 및 제한
주요 요약
세계 시장 전망
공급 및 수요 동향 분석
부문별 기회 분석
시장 역학 및 전망
시장 개요
시장 규모
시장 역학
성장 촉진요인 및 기회
성장 억제요인 및 과제
Porter's Five Forces 분석
주요 시장 인사이트
중요성공요인
경쟁도
주요 투자 기회
시장 생태계
시장의 매력 지수(2024년)
PESTEL 분석
거시경제지표
밸류체인 분석
가격 분석
규제 상황
사례 연구
기술 분석
인슐린 주사기 시장 규모 : 주사기 크기별
시장 개요
3/10 CC 주사기(0.3ml)
1/2 CC 주사기(0.5ml)
1 CC 주사기(1ml)
기타
인슐린 주사기 시장 규모 : 질병 유형별
시장 개요
1형 당뇨병
2형 당뇨병
인슐린 주사기 시장 규모 : 최종 용도별
시장 개요
병원 및 진료소
재택 케어 설정
기타
인슐린 주사기 시장 규모 : 유통 채널별
시장 개요
병원 약국
소매 약국
온라인 약국
인슐린 주사기 시장 규모 : 바늘 길이별
시장 개요
단
중
장
인슐린 주사기 시장 규모 : 제품 유형별
시장 개요
표준 인슐린 주사기
안전 인슐린 주사기
인슐린 주사기 시장 규모
북미
미국
캐나다
유럽
독일
스페인
프랑스
영국
이탈리아
기타 유럽
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카
중동 및 아프리카
GCC 국가
남아프리카
기타 중동 및 아프리카
경쟁 정보
상위 5개사 비교
주요 기업의 시장 포지셔닝(2024년)
주요 시장 기업이 채용한 전략
최근 시장 동향
기업의 시장 점유율 분석(2024년)
주요 기업의 기업 프로파일
기업의 상세
제품 포트폴리오 분석
기업의 부문별 점유율 분석
수익의 전년대비 비교(2022-2024년)
주요 기업 프로파일
Novo Nordisk A/S(Denmark)
Eli Lilly and Company(US)
Sanofi SA(France)
Becton, Dickinson and Company(BD)(US)
Terumo Corporation(Japan)
Cardinal Health Inc.(US)
Medtronic plc(Ireland)
Abbott Laboratories(US)
Nipro Corporation(Japan)
Biocon Ltd.(India)
Hindustan Syringes & Medical Devices Ltd.(India)
B. Braun Melsungen AG(Germany)
Ypsomed Holding AG(Switzerland)
Stevanato Group SpA(Italy)
Schott Pharma AG & Co. KGaA(Germany)
ApiJect Systems Corporation(US)
Teleflex Incorporated(US)
Owen Mumford Ltd.(UK)
Allison Medical Inc.(US)
결론 및 권고
AJY
영문 목차
영문목차
Global Insulin Syringes Market size was valued at USD 1.7 billion in 2023 and is poised to grow from USD 1.77 billion in 2024 to USD 2.46 billion by 2032, growing at a CAGR of 4.2% during the forecast period (2025-2032).
The global insulin syringes market is experiencing significant growth due to the alarming rise in diabetes prevalence, particularly type 2 diabetes, fueled by sedentary lifestyles, unhealthy diets, urbanization, and increasing obesity rates. The International Diabetes Federation projects that the adult diabetes population will surge from 537 million in 2021 to 783 million by 2045, creating a heightened demand for effective insulin delivery systems. As major pharmaceutical companies like Novo Nordisk shift focus from traditional human insulin pens to higher-margin GLP-1 receptor agonists, many patients, particularly in low- and middle-income countries, are left with fewer affordable options. Consequently, there's a resurgence in the use of conventional insulin syringes, especially in healthcare settings lacking advanced technologies, further boosting market demand.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Insulin Syringes market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Insulin Syringes Market Segments Analysis
Global Insulin Syringes Market is segmented by Syringe Size, Disease Type, End-Use, Distribution Channel, Needle Length, Product Type and region. Based on Syringe Size, the market is segmented into 3/10 CC Syringe (0.3ml), 1/2 CC Syringe (0.5ml), 1 CC Syringe (1ml) and Others. Based on Disease Type, the market is segmented into Type 1 Diabetes and Type 2 Diabetes. Based on End-Use, the market is segmented into Hospitals & Clinics, Homecare Settings and Others. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies and Online Pharmacies. Based on Needle Length, the market is segmented into Short, Medium and Long. Based on Product Type, the market is segmented into Standard Insulin Syringes and Safety Insulin Syringes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Insulin Syringes Market
The global increase in the elderly population is contributing significantly to the rise in diabetes prevalence, resulting in heightened insulin usage. As age-related diabetes cases continue to climb, the demand for insulin syringes is steadily on the rise. This trend is driving market expansion, as effective and regular insulin administration becomes increasingly essential for managing the health of diabetic patients. Consequently, the urgent need for insulin syringes as a critical tool in diabetes care is a primary factor propelling growth in the global insulin syringes market.
Restraints in the Global Insulin Syringes Market
A significant constraint within the global insulin syringes market arises from patients' reluctance to initiate or adhere to insulin therapy, primarily due to fear of needles and the discomfort associated with injections. This apprehension leads to infrequent use of syringes, which hinders overall market growth. The issue of patient compliance remains critical in effective diabetes management, and when individuals are deterred from regular insulin usage, it creates barriers to market expansion. Addressing these concerns is essential to increase acceptance and utilization of insulin syringes, ultimately improving diabetes care and enhancing market potential.
Market Trends of the Global Insulin Syringes Market
The Global Insulin Syringes market is witnessing a notable trend towards miniaturized syringes, specifically 0.5 ml variants, driven by the growing demand from pediatric patients and individuals with Type 1 diabetes. These smaller syringes enhance dosing accuracy and provide a more comfortable experience for users, addressing the critical need for improved patient compliance. As more healthcare providers and patients recognize the benefits of these compact devices, manufacturers are increasingly focusing on innovation to meet this demand. This shift is expected to significantly influence market dynamics, fostering growth and expanding the availability of user-friendly insulin delivery solutions worldwide.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies
Technological Analysis
Global Insulin Syringes Market Size by Syringe Size & CAGR (2025-2032)
Market Overview
3/10 CC Syringe (0.3ml)
1/2 CC Syringe (0.5ml)
1 CC Syringe (1ml)
Others
Global Insulin Syringes Market Size by Disease Type & CAGR (2025-2032)
Market Overview
Type 1 Diabetes
Type 2 Diabetes
Global Insulin Syringes Market Size by End-Use & CAGR (2025-2032)
Market Overview
Hospitals & Clinics
Homecare Settings
Others
Global Insulin Syringes Market Size by Distribution Channel & CAGR (2025-2032)
Market Overview
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Insulin Syringes Market Size by Needle Length & CAGR (2025-2032)
Market Overview
Short
Medium
Long
Global Insulin Syringes Market Size by Product Type & CAGR (2025-2032)
Market Overview
Standard Insulin Syringes
Safety Insulin Syringes
Global Insulin Syringes Market Size & CAGR (2025-2032)
North America (Syringe Size, Disease Type, End-Use, Distribution Channel, Needle Length, Product Type)
US
Canada
Europe (Syringe Size, Disease Type, End-Use, Distribution Channel, Needle Length, Product Type)
Germany
Spain
France
UK
Italy
Rest of Europe
Asia Pacific (Syringe Size, Disease Type, End-Use, Distribution Channel, Needle Length, Product Type)
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America (Syringe Size, Disease Type, End-Use, Distribution Channel, Needle Length, Product Type)
Brazil
Rest of Latin America
Middle East & Africa (Syringe Size, Disease Type, End-Use, Distribution Channel, Needle Length, Product Type)
